Recombinant Human FSH Protein，His & SUMO

Recombinant follicle-stimulating hormone (FSH) is a key hormone in the regulation of reproductive processes, primarily influencing ovarian follicle development and spermatogenesis. Traditionally, FSH was extracted from the urine of postmenopausal women, which posed limitations in terms of availability, purity, and consistency. The advent of recombinant DNA technology has revolutionized FSH production, allowing for the generation of highly purified, biologically active FSH proteins that mirror the human form. This innovation not only enhances the quality and safety of FSH in clinical settings but also enables precise dosing and standardization for fertility treatments, such as in vitro fertilization (IVF) and ovulation induction. Current research focuses on optimizing the structural and functional properties of recombinant FSH, exploring its role in various treatment protocols, and investigating the potential for improved therapeutic outcomes. Additionally, studies are examining the impact of different glycosylation patterns on FSH's biological activity, as well as the development of long-acting formulations to reduce the frequency of injections. The understanding of FSH’s mechanisms of action at the molecular level is also a pivotal area of investigation, aiming to unravel its intricate signaling pathways and interactions with other hormones. Overall, the development and research surrounding recombinant FSH represent a significant advancement in reproductive medicine, providing hope for individuals facing fertility challenges while pushing the boundaries of hormonal therapies.